TORONTO, Nov. 1, 2013 /CNW/ - The Ontario Tumour Bank (OTB) will supply
ovarian tumour samples to the Canadian Ovarian Cancer Experimental
Unified Resource (COEUR) in an effort to further enhance ovarian cancer
research in Canada, announced Dr. John Bartlett, Provincial Principal
Investigator, OTB and Director of the Ontario Institute for Cancer
Research's (OICR) Transformative Pathology Program.
"We are thrilled to be contributing these samples to COEUR and to be a
part of such an innovative and exciting initiative to discover more
about the causes of ovarian cancer and the best avenues for treatment,"
said Dr. Bartlett. "Through sharing and collaboration we are more
likely to identify the best individualized treatment strategies to
improve outcomes for patients with ovarian cancer."
The COEUR initiative, a project of the Terry Fox Research Institute,
will establish a collection of ovarian cancer samples and clinical data
from 2,000 women. Researchers will be provided with controlled access
to the resources so they can perform biomarker studies with a
particular focus on predicting response to therapy. Biomarkers are an
important tool in personalized medicine as they assist clinicians in
diagnosing an individual's cancer and choosing the most effective
treatment, potentially sparing patients unnecessary side effects and
ensuring patients are matched with the most effective treatment sooner.
"Adding the high-quality samples and clinical data of the OTB is an
important step toward reaching our goal of 2,000 ovarian cancer
samples," said COEUR principal investigator Dr. Anne-Marie Mes Masson,
a molecular oncologist at the Université de Montréal. "These samples
will make COEUR a more robust resource for researchers and enable them
to address clinical challenges to improve outcomes for women who are
treated for ovarian cancer."
The initiative also aims to accelerate research by requiring studies
that use its samples to submit the resulting research data to COEUR to
allow the creation of a database for meta-analysis. This means that
future studies using the resource will be on an even stronger footing.
With the OTB providing samples, OICR will become a consortium
institution and its researchers will be provided with free access to
the COEUR sample collection and database subject to approval of their
research project by the COEUR study committee. COEUR will provide free
access to its collection to all academic researchers across Canada
based on the scientific merit and ethics review of their research.
COEUR is funded by a five-year $5-million commitment from the Terry Fox
Research Institute and the Canadian Partnership Against Cancer. Under
the agreement between the OTB and COEUR, OICR will be reimbursed for
the cost of the provided tumour samples.
For more information on the Ontario Tumour Bank, please visit: www.ontariotumourbank.ca.
OICR is an innovative cancer research and development institute
dedicated to prevention, early detection, diagnosis and treatment of
cancer. The Institute is an independent, not-for-profit corporation,
supported by the Government of Ontario. OICR research supports more
than 1,600 investigators, clinician scientists, research staff and
trainees located at its headquarters and in research institutes and
academia across the Province of Ontario. OICR has key research efforts
underway in small molecules, biologics, stem cells, imaging, genomics,
informatics and bio-computing. For more information, please visit the
website at www.oicr.on.ca
SOURCE: Ontario Institute for Cancer Research
For further information:
Ontario Institute for Cancer Research
Contact: Christopher Needles
Manager, Strategic Communications